Cite

HARVARD Citation

    Argyropoulou, M. et al. (2019). Cost‐savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real‐world cohort. British journal of dermatology. pp. 1161-1168. [Online]. 
  
Back to record